ASX Share rice
Sat 19 Jun 2021 - 11:06:am (Sydney)

CTE Share Price

CRYOSITE LIMITEDCTEPharmaceuticals, Biotechnology & Life Sciences

CTE Company Information

Name:

Cryosite Limited

Sector:

Healthcare

Industry:

Diagnostics & Research

GIC Industry:

Life Sciences Tools & Services

GIC Sub Industry:

Life Sciences Tools & Services

Address:

13a Ferndell Street South Granville NSW Australia 2142

Phone:

61 2 8865 2000

Full Time Employees:

18

Non-Exec. Chairman & Company Sec.:

Mr. Bryan Dulhunty C.A., BEc, ACA

Chief Operating Officer of Fin. & Admin.:

Mr. Mark Edmund Payton Byrne

Chief Exec. Officer:

Mr. John Hogg

Company Overview:

Cryosite Limited engages in the supply chain logistics and management of pharmaceutical products used in clinical trials, and biological materials in Australia. It operates in two segments, Clinical Trials & Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials & Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns, and biological storage services to the clinical trial and research industry. The Cord Blood and Tissues Storage segment offers long term storage for cord blood and tissue samples. It serves research, medical, pharmaceutical, veterinary, and biotechnology industries. Cryosite Limited was founded in 1999 and is based in South Granville, Australia.

CTE Share Price Information

Shares Issued:

46.86M

Market Capitalisation:

$19.68M

Revenue (TTM):

$9.71M

Revenue Per Share (TTM):

$0.21

Earnings per Share:

$0.011

Profit Margin:

0.0535

Operating Margin (TTM):

$0.08

Return On Assets (TTM):

$0.02

Quarterly Revenue Growth (YOY):

0.178

Gross Profit(TTM):

$4M

Diluted Earnings Per Share (TTM):

$0.011

QuarterlyEarnings Growth(YOY):

-0.768

CTE CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-882,102

Change To Liabilities:

$-1,726,757

Total Cashflow From Investing Activities:

$-882,102

Net Borrowings:

$-254,600

Net Income:

$1.48M

Total Cash From Operating Activities:

$1.28M

Depreciation:

$437.55K

Other Cashflow From Investing Activities:

$27.75K

Change To Inventory:

$-25,021

Change To Account Receivables:

$-446,935

Capital Expenditures:

$0.91M

CTE Income Statement

Income Date:

2020-06-30

Income Before Tax:

$1.77M

Net Income:

$1.48M

Gross Profit:

$3.95M

Operating Income:

$1.67M

Income Tax Expense:

$285.33K

Total Revenue:

$8.92M

Total Operating Expenses:

$2.28M

Cost Of Revenue:

$4.97M

CTE Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$20.22K

Total Liabilities:

$23.79M

Total Stockholder Equity:

$-286,810

Other Current Liabilities:

$2.60M

Total Assets:

$23.50M

Common Stock:

$5.86M

Other Current Assets:

$1.50M

Retained Earnings:

$-6,167,211

Other Liabilities:

$19.36M

Other Assets:

$14.17M

Cash:

$4.06M

Total Current Liabilities:

$3.37M

Property - Plant & Equipment:

$2.29M

Net Tangible Assets:

$-396,494

Total Current Assets:

$6.93M

Net Receivables:

$0.96M

Short-Term Investments:

$16.58M

Inventory:

$47.88K

Accounts Payable:

$389.34K

Non Currrent Assets (Other):

$11.90M

Short-Term Investments:

$16.58

Non Current Liabilities (Other):

$527.83K

Non Current Liabilities Total:

$20.42M

CTE Share Price History

CTE News

10 Jun, 2021
Investors who take an interest in Cryosite Limited ( ASX:CTE ) should definitely note that the Non Executive Director...

CTE Dividend Payments

EX-Date Dividend Amount
2012-03-16$0.0050
2012-09-28$0.0050
2013-03-18$0.0050
2013-09-23$0.0100
2014-03-17$0.0050
2014-09-08$0.0100
2015-03-13$0.0050
2015-09-08$0.0050
2016-03-11$0.0050
2016-09-07$0.0050
2017-03-14$0.0050

CTE Dividends (last 6 Years)